CellPro (US) Conformatie Europeene (CE)-marks Ceprate:
This article was originally published in Clinica
CellPro (US) has CE-marked its Ceprate SC Stem Cell Concentration System following an audit to EN 29002/46002 by TUV Product Services of Munich, Germany. It claims to be "among the first US biotechnology companies" to display the CE marking.
You may also be interested in...
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.